Impact of Melatonin in Solid Organ Transplantation-Is It Time for Clinical Trials? A Comprehensive Review

Area of Science:

• Transplantation immunology
• Organ preservation
• Regenerative medicine

Background:

• Solid organ transplantation is the primary treatment for end-stage organ disease.
• A critical shortage of donor organs leads to significant patient mortality on waiting lists.
• Novel strategies are essential to address the organ supply deficit.

Purpose of the Study:

• To review current data on melatonin's potential role in solid organ transplantation.
• To assess the feasibility of clinical translation for melatonin-based strategies.
• To highlight the need for further clinical evaluation.

Main Methods:

• Comprehensive literature review of experimental studies on melatonin and organ transplantation.
• Analysis of data regarding melatonin's effects on organ donor pools and graft protection.
• Evaluation of existing research for clinical applicability.

Main Results:

• Experimental evidence suggests melatonin may enhance the donor organ pool.
• Melatonin demonstrates potential for protecting transplanted organs (grafts).
• Current research remains at the experimental stage, lacking clinical validation.

Conclusions:

• Melatonin presents a promising avenue for addressing donor organ shortages.
• Clinical studies are necessary to validate melatonin's efficacy and safety in transplantation.
• Further research could lead to improved outcomes for transplant recipients.